These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2444745)

  • 1. [A modified method of determining antithrombin III activity by diffusion in thrombin agarose].
    Bashkov GV; Kalishevskaia TM
    Lab Delo; 1987; (8):580-4. PubMed ID: 2444745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of 3 methods of study of antithrombin III].
    Nakabanda A; Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1984; (5):276-9. PubMed ID: 6204109
    [No Abstract]   [Full Text] [Related]  

  • 3. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
    Bashkov GV
    Biull Eksp Biol Med; 1990 Aug; 110(8):133-6. PubMed ID: 2291954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV; Kalishevskaia TM
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the development of acquired antithrombin III deficiency in the experimental nephrotic syndromes.
    Bashkov GV; Kalishevskaya TM; Strukova SM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):324-8. PubMed ID: 2465224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III, protein S, and coagulation in the nephrotic syndrome.
    Schnaper HW
    Pediatr Nephrol; 2001 Jan; 16(1):98. PubMed ID: 11198616
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency.
    Green RA; Kabel AL
    J Am Vet Med Assoc; 1982 Nov; 181(9):914-7. PubMed ID: 6815144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III deficiency and thromboembolism.
    Thaler E; Lechner K
    Clin Haematol; 1981 Jun; 10(2):369-90. PubMed ID: 7032781
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein C and anti-thrombin III levels in nephrotic syndrome and amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Pediatr Nephrol; 1992 Jan; 6(1):122. PubMed ID: 1536733
    [No Abstract]   [Full Text] [Related]  

  • 16. [Formation of thrombin and its inactivation by antithrombin III following repeated intravenous injections of tissue thromboplastin in animals].
    Pastorova VE
    Biull Eksp Biol Med; 1986 May; 101(5):527-9. PubMed ID: 3708129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on antithrombin III in nephrotics].
    Chen WY; Chen SY; Shen MC; Yen TS; Hsieh BS; Tsai TJ; Hsu HC
    Taiwan Yi Xue Hui Za Zhi; 1985 Apr; 84(4):448-56. PubMed ID: 3860616
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M; Cristea A; Vonica A; Lascu I
    Med Interne; 1988; 26(3):191-7. PubMed ID: 3187359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.